Yesim Ozguler Selected Research

Yesim Ozguler Research Topics

5	Tuberculosis (Tuberculoses) 01/2022 - 01/2015
2	Latent Tuberculosis 01/2022 - 03/2016
2	Uveitis 12/2018 - 12/2016
1	Neoplasms (Cancer) 11/2023
1	Infertility (Sterility) 11/2023
1	Communicable Diseases (Infectious Diseases) 12/2022
1	COVID-19 01/2022
1	Rheumatoid Arthritis 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Ankylosing Spondylitis 01/2020
1	Aneurysm (Aneurysms) 12/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018
1	Ulcer 11/2018
1	Inflammation (Inflammations) 11/2018
1	Infections 12/2015
1	Hemoptysis 12/2015
1	Aspergillosis 12/2015
1	Thrombosis (Thrombus) 12/2015

3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 12/2015
2	AnticoagulantsIBA 01/2022 - 12/2018
2	AntibodiesIBA 01/2020 - 12/2018
2	canakinumab FDA Link 12/2016 - 12/2015
1	AA amyloidosisIBA 12/2022
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	favipiravirIBA 01/2022
1	Colchicine FDA LinkGeneric 01/2022
1	Interferon-alpha (Interferon Alfa)IBA 01/2022
1	GlucocorticoidsIBA 12/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2016
1	Etanercept (Enbrel)FDA Link 12/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2016
1	Methotrexate (Mexate)FDA LinkGeneric 12/2016
1	Prednisolone (Predate)FDA LinkGeneric 12/2015
1	Infliximab (Remicade)FDA Link 12/2015
1	Adalimumab (Humira)FDA Link 12/2015

1	Duration of Therapy 11/2023
1	Therapeutics 12/2016